CONMED Shares Plunge After Exiting Gastroenterology Lines

CONMEDs stock plummets by over six percent after announcing plans to exit gastroenterology product lines, potentially improving gross profit margin. Despite reaffirming financial guidance, investors express concern over losing a significant revenue source, causing shares to drop by over thirty-eight percent this year.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.